Induction of p75NGFR in human diabetic neuropathy

Journal of the Neurological Sciences

Volumn 135, Issue 1, 1996, Pages 55-62

  Scarpini, Elio ^a   Conti, Giancarlo ^a   Chianese, Luigia ^a   Baron, Pierluigi ^a   Pizzul, Silvia ^a   Basellini, Aldo ^a   Livraghi, Simona ^b   Scarlato, Guglielmo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Diabetes mellitus; Ischemic neuropathy; NGF, diabetic neuropathy; p75NGFR

Indexed keywords

ENDOGENOUS COMPOUND; NERVE GROWTH FACTOR RECEPTOR; CD57 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MALE; PRIORITY JOURNAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ISCHEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL NERVE; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD57; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; MIDDLE AGED; PERIPHERAL NERVES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR;

EID: 0029671108     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00260-9     Document Type: Article

References (44)

1. Apfel, S.C., Lipton, R.B., Arezzo, J.C., Kessler, J.A. (1991) Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 29: 87-89.
2. Apfel, S.C., Arezzo, J.C., Lipton, L., Kassler, J.A. (1992) Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31: 76-80.
3. Apfel, S.C., Arezzo, J.C., Brownlee, M., Federoff, H., Kessler, J.A. (1994) Nerve growth factor protects against experimental diabetic sensory neuropathy. Brain Res 634/1: 712.
4. Berg, M.M., Sternberg, D.W., Hempstead, B.L., Chao, M.V. (1991) The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF induced tyrosine phosphorylation. Proc Natl Acad Sci USA 88, 7106-7110.
5. Bianchi, R., Berti-Mattera, L.N., Fiori, M.G., Eichberg, J (1990) Correction of altered metabolic activities in sciatic nerves of streptozocin-induced diabetic rats. Diabetes 39: 782-788.
6. Bresolin, N., Moggio, M., Bet, L., Gallanti, A., Prelle, A., Nobile-Orazio, E., Adobbati, L., Ferrante, C., Pellegrini, G., Scarlato, G. (1987) Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol 21: 564-572.
7. Budzisch, M.R., Baumgarten, H.G., Blottner, D. (1992) Nerve growth factor Receptor (NGF-R) in peripheral nerve of experimental diabetic neuropathy in rats: a temporal immunocytochemical analysis. Clin Neuropathol 4 (Abstr.): 178.
8. Conner, J.M., Fass-Holmes, B., Varon, S. (1994) Changes in NGF immunoreactivity following entorhinal cortex lesions; possible molecular mechanism regulating cholinergic sprouting. J Comp Neurol 345 (3): 409-418.
9. Conti, G., Baron, P.L., Bianchi, R., Scarpini, E., Pleasure D., Scarlato, G (1993) NGF receptor expression within the peripheral nervous system during experimental diabetic neuropathy. Peripheral Nerve Study Group, 11th Biennal Meeting, Jakobsberg, Germany, p. 115.
10. Cordon-Cardo, C., Tapley, P., Jing, S., Nanduri, V., O'Rourke, E., Lamballe, F., Kovary, K., Klein, R. Jones, K.R. Reichardt, L.F , Barbacid, M. (1991) The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 66: 173-183.
11. Diemel, L.T., Stevens, E.J., Willars, G.B., Tomlinson, D.R. (1992) Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes, effects of insulin and aldose reductase inhibition. Neurosci Lett 137 253-256.
12. Dyck, P.J., Karnes, J.L., Daube, J. O'Brien, P. Service, F.J. (1985) Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108 861-880
13. Dyck, P.J., Lais, A., Karnes, J.L., O'Brien, P , Rizza, R. (1986) Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy Ann Neurol 19: 425-439.
14. Ekstrom, P.A.R., Tomlinson, D.R (1989) Impaired nerve regeneration in streptozocin-diabetic rats. J Neurol Sci 93: 231-237.
15. Faradji, V., Sotelo, J. (1990) Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 81: 402-406.
16. Fernyhough, P., Diemel, L.T., Brewster, W.J., Tomlinson, D.R. (1995) Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 64: 1231-1237.
17. Frazier, W.A., Hogue-Angeletti, R., Bradshaw, R.A. (1972) Nerve growth factor ed insulin, structural similarities indicate an evolutionary relationship reflected by physiological action. Science 76: 482-488.
18. Frazier, W.A., Hogue-Angeletti, R., Bradshaw, R.A (1973) Nerve growth factor versus insulin. Science 73 1301-1302
19. Greene, A., Sima, A.F., Stevens, J., Feldman, M.J. Lattimer, S.A (1992) Diabetes complications : neuropathy, pathngenetic considerations. Diabetes Care 15: 1902-1925.
20. Hallbook, F., Ibanez, C., Persson, H., (1991) Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in xenopus ovary. Neuron 6: 845-858.
21. Hellweg, R., Hartung, H.D. (1990) Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26: 258-267.
22. Hellweg, R., Wohrl, M., Hartung, H.D., Stracke, H., Hook, C., Fedelin, K. (1991) Diabetes mellitus associated decrease in nerve growth factor levels is reversed by allogenic pancreatic islet transplantation. Neurosci Lett 125: 1-4.
23. Hellweg, R., Raivich, G., Hartung, H.D., Hock, C., Kreutzberg, G.W. (1994) Axonal transport of endogenous NGF and NGF receptor in experimental diabetic neuropathy. Exp Neurol 130: 24-30.
24. Hempstead, B.L., Martin-Zanca, D., Kaplan, D.R., Parada, L.F., Chao MV (1991) High-affinity NGF binding requires coexpression of the trk proto oncogene and the low affinity NGF receptor. Nature 350: 678-683.
25. Hempstead, B.L., Schleifer, L.S., Chao, M.V. (1989) Expression of functional nerve growth factor receptors after gene transfer. Science 243: 373-375.
26. Ibanez, C.F., Ilag, L.L., Murray-Rust, J., Persson. H. (1993) An extended surface of binding to TRK tyrosine kinase receptors in NGF and BDNF allow the engineering of multifunctional pan-neurotrophin. EMBO J 61: 1430-1437.
27. Ip, N.Y., Stitt, T.N., Tapley, P.P., Klein, R., Glass, D.J., Fandl, J., Greene, L.A., Barbacid, M.. Yankopoulos, G.D. (1993) Similarities and differences in the way neurotrophins interact with the trk receptors in neuronal and nonneuronal cells. Neuron 10: 137-149.
28. Jakobsen, J., Brimijoin, S., Skau, K., Sidenius, P., Wells, D. (1981) Retrograde axonal transport of transmitter enzymes, fucose-labeled protein and nerve growth factor in stieptozocin-diabetic rats. Diabetes 30: 797-803.
29. Kasayama, S. and Oka, T. (1989) Impaired production of nerve growth factor in the submandibular gland of diabetic mice. Am J Physiol 257: E400-E404.
30. Klein, R., Jing, S., Nanduri, V., O'Rourke, E., Barbacid, M. (1991) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65: 189-197.
31. Llewelyn, J.G. and Thomas, P.K. (1987) Perineurial sodium-potassium-ATPase activity in streptozocin-diabetic rats. Exp Neuropathol 97: 375-382.
32. Longo, F.M. (1986) Delayed nerve regeneration in streptozocin diabetic rats. Muscle Nerve 9: 395-393.
33. Ordonez, G., Fernandez, A., Perez, R., Sotelo, J. (1994) Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. J Neurol Sci 121: 163-166.
34. Pleasure, S.J., Reddy, U.R., Venkatakrishnan, G., Roy, A.K., Chen, J., Ross, A.H., Trojanowski, J.Q., Pleasure, D.E., Lee, V.M.Y. (1990) Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high-and low-affinity NGF receptors but not NGF-mediated differentiation. Proc Natl Acad Sci USA 87: 8496-8500.
35. Ross, A.H., Grob, P., Bothwell, M., Elder, D.E., Ernst, C.S., Marano, N., Ghrist, B.F.D., Slemp, C.C., Herlyn, M., Atkinson, B., Koprowski, H. (1984) Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci USA 81: 6681-6685.
36. Ross, A.H., Pleasure, D., Sonnenfeld, K., Atkinson, B., Kreider, B., Jackson, D.M., Taff, I., Scarpini, E., Lisak, R.P., Koprowski, H. (1986) Expression of melanoma-associated antigens by normal and neurofibroma Schwann cells. Cancer Res 46: 5887-5892.
37. Scarpini, E., Ross, H.A., Rosen, J.L., Brown, M.J., Rostami, A., Koprowski, H., Lisak, R.P. (1988) Expression of nerve growth factor receptor during human peripheral nerve development. Dev Biol 125: 301-310.
38. Scarpini, E., Beretta, S., Ross, H.A., Moggio, M., Jann, S., Pleasure, D., Scarlato, G. (1989) Rapid quantitative immunohistochemical assessment of human peripheral neuropathies using a monoclonal antibody against nerve growth factor receptor. J Neurol 236: 439-444.
39. Scarpini, E., Lisak, R.P., Beretta, S., Velicogna, M., Doronzo, R., Moggio, M., Jann, S., Scarlato, G. (1990) Quantitative assessment of class II molecules in normal and pathological nerves. Brain 113 659-675.
40. Scarpini, E., Bianchi, R., Moggio, M., Sciacco, M., Fiori, M.G., Scarlato, G. (1993) Decrease of nerve Na + ,K + -ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci 120: 159-167.
41. Schuller-Petrovic, S., Gebhart, W., Lassmann, H., Rumpold, H., Kraft, D. (1983) A shared antigenic determinant between natural killer cells and nervous tissue. Nature 306: 179-181.
42. Sobue, G., Yasuda, T., Mitsuma, T., Ross, A.H., Pleasure, D. (1988) Expression of nerve growth factor receptor in human peripheral neuropathies. Ann Neurol 24: 64-72.
43. Stoll, G., Griffin, J., LI, C., Trapp, B. (1989) Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 18: 671-683.
44. Vital, A., Vital, C., Brechenmacher, J.M. et al. (1986) Quantitative, histological and ultrastructural studies of peripheral nerve in arteriosclerotic non-diabetic patients. Clin Neuropathol 5: 224-229.